Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

 210.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 258.00p
  • 52 Week Low: 177.20p
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 0
  • Market Cap: £457.65m
  • RiskGrade: 156

Tuesday broker round-up

By Conor Coyle

Date: Tuesday 14 Mar 2017

LONDON (ShareCast) - (ShareCast News) - Amec Foster Wheeler: Citigroup downgrades to Neutral/High Risk with a target price of 580p.
Restaurant Group: Barclays reiterates Equal Weight with a target price of 400p.

Spire Group: Berenberg reiterates Buy with a target price of 360p.

Paysafe: Macquarie reiterates Outperform with a target price of 444p.

Dechra Pharmaceuticals: RBC reiterates Outperform with a target price of 1890p.

Wood Group: UBS maintains Neutral with a target price of 875p.

Esure: JPMorgan reiterates Overweight with a target price of 260p.

Acacia Mining: Peel Hunt upgrades to Hold with a target price of 434p.

JD Wetherspoon: Peel Hunt upgardes to Hold with a target price of 925p.

Advanced Medical Solutions: Numis downgrades to Add with a target price of 275p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 258.00p
52 Week Low 177.20p
Volume 0
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page